1. Scrip
  2. >>Business

Deal Watch: Allergan Deal-Binge Includes Derm, NASH Buys

 
• By Joseph Haas

Golden Meditech and MD Anderson establish startup focused on umbilical cord blood-derived T-regulatory therapies. Bayer and Evotec sign their second collaboration in four years, this time focused on renal disease.

Business Balance - A businessman carrying paperwork walking over a tight rope.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Sept.9-22. Deal Watch is supported by deal intelligence from Strategic Transactions.

Allergan PLC staked its ground in the developing non-alcoholic steatohepatitis (NASH) field with the purchase of a pair of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business